Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea.

< BACK TO ARCHIVE


2022 Mar 17


J Ovarian Res


http://www.ncbi.nlm.nih.gov/pubmed/35300713?dopt=Abstract


15


1

BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea.

Authors

BDNF and TrKB expression levels in patients with endometriosis and their associations with dysmenorrhoea.
Wang S, Duan H, Li B, Hong W, Li X, Wang Y, Guo Z C
J Ovarian Res. 2022 Mar 17; 15(1):35.
PMID: 35300713.

Abstract

Brain-derived neurotrophic factor (BDNF) is a known regulator of the development and maintenance of chronic pain in various chronic disorders. Together with its high-affinity tyrosine kinase type B (TrKB) receptor, BDNF is extensively expressed in the mammalian female reproductive system. However, BDNF and TrKB expression in different stages of endometriosis and the relationship between the expression of each in ectopic lesions and endometriosis pain remain unclear.
Read This Paper